How to Buy Supernus Pharmaceuticals Stock

Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for central nervous system (CNS) disorders within the United States.

Supernus Pharmaceuticals stock last closed at $47.41, up 1.94% from the previous day, and has increased 48.99% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.84 percentage points. Supernus Pharmaceuticals stock is currently +51.23% from its 52-week low of $31.35, and -20.56% from its 52-week high of $59.68.

At the moment, there are 58.04M SUPN shares outstanding. The market cap of SUPN is $2.75B. In the past 24 hours, 886,000 SUPN shares were traded.

How to Buy Supernus Pharmaceuticals Stock

Wondering how to invest in Supernus Pharmaceuticals stock? Here's how.

  1. Choose where to buy Supernus Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Supernus Pharmaceuticals stock.
  2. Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your brokerage account: Select your payment method and add your details.
  4. Analyze Supernus Pharmaceuticals stock: The Supernus Pharmaceuticals ticker symbol is SUPN. Is Supernus Pharmaceuticals stock a good investment? Should you buy shares of SUPN? How do SUPN's underlying business fundamentals look? Do top analysts think Supernus Pharmaceuticals is a good buy? Why has SUPN's stock price moved recently? (Hint: Our stock market research website can help you decide if SUPN is a good stock to buy).
  5. Place your SUPN purchase: Decide if you will purchase SUPN shares at the current market price or use a limit order to buy SUPN shares at a specific price.
  6. Keep tabs on your investment in SUPN: Create a watchlist to important notifications about your new investment in Supernus Pharmaceuticals shares.

Step 1: Choose where to buy Supernus Pharmaceuticals stock

You need a brokerage account in order to access the NASDAQ market and buy SUPN stock.

A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to global financial markets: From Technology to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've picked your brokerage, it's time to fill out some personal info so you are able to buy SUPN stock today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal info to start a new brokerage account.
  1. Submit your info by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you have created your account on the best stock app for beginners, you need to deposit funds:

Check out the tutorial below to see the process of transferring money into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Supernus Pharmaceuticals stock

After you have chosen the best place to buy Supernus Pharmaceuticals stock, it's important to evaluate their stock prior to buying, so you actually comprehend the risk and opportunity.

Supernus Pharmaceuticals shares at a glance

SUPN Price
$47.41
1w %
5.03%
1y %
48.99%
5y %
51.04%
P/E
-92.96x
P/B
2.56x
P/S
3.52x
PEG
N/A
Revenue
$776.83M
Earnings
-$29.02M
Fore. Rev. Growth
15.41%
Fore. Earn. Growth
N/A
Market Cap
$2.75B
Next Earnings
Aug 4, 2026
Next Dividend
N/A

SUPN Due Diligence Checks

WallStreetZen was designed to help part-time investors do better fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on SUPN's stock page.

Is SUPN stock undervalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge SUPN's true value.

Using relative valuations measures:

  • SUPN may be overvalued based on its P/B ratio of 2.56x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 1.54x

You can do more valuation research on SUPN's stock here.

How do SUPN Financials look?

Positive Health Checks:

  • There are more short-term assets than long-term liabilities on the SUPN balance sheet.
  • Total SUPN debt is lower than 5 years ago, relative to shareholder equity.
  • SUPN's operating cash flow of $83.26M allows it to safely service it's debt of $30.27M.
  • There are more short-term assets than short-term liabilities on the SUPN balance sheet.
  • SUPN has a low debt to equity ratio of 0.39.

Negative Health Checks:

  • SUPN earnings of -$49.15M is not sufficient to cover its interest payments.
  • SUPN profit margin has gone down from 9.3% to -3.7% in the past year.

You can dive deeper into what analysts are saying on the Supernus Pharmaceuticals stock forecast page.

SUPN Technical Indicators

SMA10
45.44
SMA20
45.02
SMA50
47.32
SMA100
49.38
SMA200
48.99
MACD
-0.17
MACD Signal
-0.68
MACD Histogram
0.51
RSI
58.62
Stochastic %K
92.03
Stochastic %D
88.11
StochRSI %K
96.23
StochRSI %D
95.14

SUPN Earnings

Last year, SUPN revenue was $776.83M. In the past five year, SUPN's revenue has gone up by 6.9% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 9.57%.

Learn more about SUPN's earnings and revenue performance here.

Latest Insiders Trades at SUPN

Over the past 12 months, insiders at SUPN have bought more shares than they have sold.

Padmanabh P. Bhatt, Sr. VP of IP CSO of SUPN, was the latest SUPN insider to buy. They bought $285,650.00 worth of SUPN stock on Mar 18, 2026.

Research more about who owns SUPN stock here.

Can I get consistent income from SUPN stock?

No, Supernus Pharmaceuticals doesn't provide an income stream by paying out dividends.

What do other investors have to say about SUPN?

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to learn what other community members have to say.

Step 5: Place your SUPN purchase

You have two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are usually fine for most investors.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at a particular dollar amount, place a limit order.

Click the Open Trade button and your broker will place the order.

If you want more help with buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep tabs on your investment in SUPN

Now that you own some SUPN stock, you'll want to keep up with your company.

Put SUPN on a watchlist to get notified of the latest news about your SUPN stock.

SUPN Feed

How to Buy Stock in Supernus Pharmaceuticals

To reiterate, here are the 6 steps to buy stock in Supernus Pharmaceuticals:

  1. Choose where to buy Supernus Pharmaceuticals stock
  2. Create your brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Supernus Pharmaceuticals stock
  5. Place your SUPN purchase
  6. Keep tabs on your investment in SUPN

If you require a online brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to watch your investment in Supernus Pharmaceuticals, click below.

NASDAQ: SUPN
$47.41+0.90 (+1.94%)
Updated Jul 1, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: SUPN
$47.41+0.90 (+1.94%)
Updated Jul 1, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Supernus Pharmaceuticals share?

As of Jul 1, 2026, it costs $47.41 to buy one share of Supernus Pharmaceuticals stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.211 shares of SUPN.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Supernus Pharmaceuticals stock?

One way to place an order for Supernus Pharmaceuticals stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.